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INTRODUCTION
However the advances in diagnostic examinations, in
monitoring and hemodynamic support methods and in the
surgical repair techniques that have occurred over the last
few years, aorta diseases are still a significant cause of
cardiovascular mortality and morbidity and  a continuous
challenge for cardiologists and surgeons.
In cases of acute dissection (AD), the consensus
regarding the necessity of immediate surgery is well
stablished. However, even after more than three decades,
the correct moment to intervene in degenerative diseases of
the ascending aorta, which determine its asymptomatic
dilation, are still under discussion and have been the subject
of many recent publications. The same can be said for the
management of the aortic root and the aortic valve.
When the transverse arch is involved, the controversies
are focused on the definition of when and to what extent the
arch must be included in reconstruction, and in the choice
of the best method of cerebral protection. The types of
protection may include hypothermic cardiocirculatory arrest,
venous retrograde perfusion, selective cerebral perfusion
and more recently anterograde perfusion through
subclavian-axillary axis.
In the treatment of the descending aorta and thoracic-
abdominal diseases, spinal cord ischemia is still the main
concern, with variable but significant involvement, in the
different approaches described. This was one motivation
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In the choice of surgical reconstruction technique,
three questions must be considered: 1. – The diameter
and the condition of the aortic root and of the Valsalva’s
sinus at the moment of the intervention and if possible,
prior to the acute event; 2. – the condition of the aortic
valve; 3. – the extent or existence of injury to the intima
of the transverse arch.
If the diameter of the ascending aorta and of the aorta
root are normal and there is no misalignment of the aortic
valve commissural plane, nor is there distortion of the
coronary ostia, the repair usually involves the use of a
straight Dacron graft, anastomosed near to the aortic
sinotubular junction. If there is a loss of support of one or
more commissures in the aortic valve, they should be
resuspended during the repair of the commissural angles,
before the insertion of the straight graft. However, if it is
impossible to repair the aortic insufficiency by valvuloplasty
or if the aortic valve is bicuspid, replacement must be
performed using a prosthesis, before the supra-commissural
implant of the graft [6-8], although some authors report
success with the repair of bicuspids valves [9].
The conventional approach to surgical repair of type-A
dissections is median sternotomy with the CPB circuit
established by cannulation of the right atrium (RA) and of
the femoral artery, generally utilizing moderate hypothermia
of from 28 ºC to 32 ºC.
When aortic dissection occurs in a previously dilated
ascending aorta or in patients with annulus-aortic ectasia,
associated with Marfan’s syndrome or not, the surgical repair
necessarily requires the replacement of the aortic valve, of
the sinotubular junction and of the Valsalva’s sinuses and
re-implantation of the coronary ostia, utilizing a composite
graft for the valvar prosthesis and a Dacron mesh, known
as a valved tube [10,11].
In the technique originally described by Bentall & De
Bono [12], the coronary ostia are included in the ascending
portion of the Dacron tube, by direct anastomoses after
valve implantation. The significant incidence of late pseudo-
aneurysms, associated with the difficulty of direct re-
implantation of the coronaries, in cases of not so significant
dilations of the Valsalva’s sinus, supports the use of a
modification proposed by Kouchoukos et al. [13] in which
the coronary ostia are excised and implanted in the tube in
the form of buttons. This technique denominated ‘button
Bentall’ has presented with low hospital mortality and a
lower incidence of complications [14-16]. Alternatively, the
modification proposed by Cabrol et al. [17] in which a PTFE
graft is connected to the ascending portion of the Dacron
tube and anastomosed end-to-end to the coronary ostia
may be useful in old patients or in cases in which there is a
necessity of very complex reconstruction of the other
segments of the thoracic aorta.
for the development of self-expanding stents. Additionally,
in cases of degenerative aneurysms, results from recent
studies on the prediction of dissection and rupture rates,
probably will change the decision of intervention based
exclusively  on the diameter, allowing more individualized
decisions including factors such as age, co-morbidities and
experience of the surgical team.
Concerning abdominal aorta, the classic indication for
surgical repair of asymptomatic infra-renal aneurysms, larger
than 4 cm in diameter, may be modified by the results of
recent European and North-American trials. Similarly,
experience with endoluminal exclusion, using stents
described in many studies that compare this technique with
open surgery, has been the subject of discussions and a
consensus is still non existing.
These guidelines aim at critically reviewing the
indications and the surgical results in the treatment of
several aortic diseases, utilizing the degree of evidence as
proposed by the American Heart Association / American
College of Cardiology and are classified as:
Class I: situations in which there is evidence or general
agreement that the procedure is beneficial and effective.
Class II: situations in which there is conflicting evidence
or divergences over the usefulness and efficacy of the
procedure or treatment.
Class IIa: situations in which the weight of evidence and
opinions encourages the use of the procedure or treatment
Class IIb: situations in which the utilization and the
efficacy of the procedure or treatment are not well supported
by evidence and opinions
Class III: situations in which there is evidence or general
agreement that the procedure or the treatment is not
beneficial and may even be deleterious.
Level of evidence A: data obtained from several
randomized trials or a meta-analysis of randomized clinical
trials.
Level of evidence B: data obtained from just one
randomized clinical assay or from several non-randomized
studies.
Level of evidence C: data obtained from consensual
opinions of specialists on the matter.
ACUTE AORTIC DISSECTIONS
Acute Type-A Dissections
In ascending aortic dissections, surgical intervention
must be immediate with the principal aim of avoiding rupture
and death by cardiac tamponade. Additional aims include
repairing aortic regurgitation when present, avoiding
myocardial ischemia, occluding the site of intima laceration
and re-directing the flow through the true lumen to the supra-
aortic branches and to the descending aorta [1-7].
3The utilization of autograft or pulmonary valvar
homograft for the reconstruction of the aortic root, although
recommended by some authors [18-21], has presented a high
incidence of reoperations due to long-term degeneration
[22] and must be reserved for specific cases, especially when
endocarditis is associated[23].
Recently, techniques of preservation and remodeling of
the aortic valve and of the aortic root have been suggested
by authors including David & Feindel [24] and Sarsam &
Yacoub [11]. In these techniques, the coronary ostia are
excised and the sinotubular junction is trimmed again
between 3 and 5 mm above the annulus, maintaining the
cuspids and the insertion line of the commissural angles
intact; a line of individual sutures using Teflon pledgets
reinforces the remaining annulus-aortic junction, which is
anastomosed to the Dacron graft; and finally, the coronary
buttons are re-implanted similar to the Bentall button
technique. As the remodeling techniques are more complex
and generally demand more time than others which use
valved tubes, they must be employed by very experienced
surgeons in elective situations, leaving procedures that use
composite grafts as is recommended in annulus-aortic
ectasia [23]. If the delamination of the aortic wall affects the
coronary ostia, impeding satisfactory reconstruction, the
alternative is to use only saphenous vein grafts.
In type-A dissections, for a better hemostasis of the
proximal and distal sutures, Teflon sheets, tissue adhesives
such as the gelatin-resorcine-formol biological glue (GRF)
or both may be used; traditionally, the leaflets separated by
the false lumen are joined by a suture line which includes a
Teflon sheet placed between the leaflets or placed as a
external reinforcement. Even though there is no consensus
in respect to the benefit of the biological adhesives and this
product has not been approved for use in the USA, the GRF
is recommended by many authors, as an adjuvant technique
[23] or in isolation [25]. With the same purpose, and already
with the recent acceptance for clinic use in the USA, can be
used the Cryolife Bioglue adhesive.
Despite of the excellent surgical results of some groups
that report a hospital mortality of between 6% and 12%
[3,4,6,7,16,25-28], the International Registry of Acute Aortic
Dissection [29], in a retrospective evaluation of 464 cases
of acute aortic dissections attended in 12 reference centers
in the USA between 1996 and 1998, showed a surgical
mortality of 26% in acute type-A dissections, a level closer
to the average in our setting.
When the aortic dissection involves the transverse arch,
the discussion in the different approaches usually  is
focalized on: 1) when to include the arch in the surgical
repair; 2) how and to what extent to reconstruct it and 3)
what is the best method of cerebral protection to be
employed.
It is generally accepted that, when the intimal injury does
not affect the inside the transverse arch, it can be repaired
through an open approach (without clamping), joining the
leaflets of the aortic wall, anastomosing the ascending aorta
graft and redirecting the flow to the true lumen, a technique
described as hemi-arch repair [30-36]. However, in around
10% to 20% of aortic dissections, the intimal injury occurs
inside the transverse portion of the arch, which makes a
complete reconstruction indispensable including re-
implantation of the supra-aortic trunks, as a block or
individually [36].
This decision is frequently difficult, as the morbidity
and mortality rates of total repair of the arch seem to be
substantially higher than hemi-arch repair, because of the
longer time of cardiocirculatory arrest (CCA) and more
intense hypothermia, which means a significant incidence
of permanent brain injury and bleeding due to dyscrasia.
In a historical series of the Texas Heart Institute between
1976 and 1982, 60 cases of aortic dissection involving the
arch with the use of hypothermic CCA, Livesay et al. [37]
reported re-intervention rates for bleeding and postoperative
stroke of 19% and 10% respectively.
In the recent experience of the Mount Sinai Medical
Center Group, total replacement of the transverse arch was
employed in 11 of 19 cases of type-A aortic dissection, with
a mean CCA time under deep hypothermia of 56 minutes,
with an incidence of excessive bleeding (which justified the
use of peri-aortic shunts to the right atrium) in 40% of the
patients [38].
Borst et al. [34] utilizing the hemi-arch repair or total arch
reconstruction techniques, in 92 patients with aortic
dissection, demonstrated that the mean CCA time doubled
and the mortality tripled using the second procedure (17
minutes versus 34 minutes and 12% versus 36%,
respectively). Similarly, Grawford et al. [33], studying 82
patients with type-A aortic dissections reported a
significantly higher mortality rate in total replacement of the
arch (31%), than in restricted intervention of the ascending
aorta or a partial repair of the arch (17%).
These findings, as well as other reports [30,31,39,40],
justify a carefull approach of the arch, with preference
for the hemi-arch repair technique with open anastomosis
and the adjuvant use of biological adhesive, except for
cases with much intra-arch destruction or discontinuity
of the descending portion of the thoracic aorta; in these
situations the best alternative is to implant a Dacron
tubular graft in the descending aorta, with the distal end
free without anastomosis (“elephant’s trunk”) and re-
implant the supra-aortic branches [41,42]. In late outcome,
if it is necessary to repair the descending aorta, the free
end of the graft can be directly anastomosed to the aortic
wall or extended by means of an additional tube to more
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4distal segments using left thoracotomy.
Among the methods described for cerebral protection
during interventions of the transverse arch, the most utilized
have been 1) CCA under deep hypothermia, 2) hypothermic
CCA with retrograde cerebralperfusion and 3) hypothermic
CCA with anterograde cerebral perfusion through the carotid
artery or more recently, through the subclavian-axillary axis.
As early as the 1970s and 1980s, hypothermic CCA was
confirmed as the  method of choice of cerebral protection as
it is easy to inspect the arch in respect to intimal injury, to
allow repair completely along its length, including the
proximal portion of the descending aorta and to impede aorta
clamping near the arch from creating sites of dissection near
the distal anastomosis [30,37,38,43]. The technique consists
of establishing CPB by cannulization of the femoral artery,
slow cooling to 18 or 20ºC (temperatures at which the
metabolic rate is 18% of normal), and the use of iced bags
for topical cooling of the head and neck.
Rewarming must also be slow, somewhere close to 1ºC
each 3 minutes to minimize hemolysis and the deleterious
effects to coagulation factors. Several groups have shown
that hypothermic CCA is effective and safe in respect to
neurological morbidity, if the period of CCA is no more than
45 minutes, with a stroke rate of between 3% and 12%
[34,37,44]. Even so, authors such as Ergin et al. [45] report
favorable results with up to 60 minutes of CCA and suggest
that neurologic injury is more related to the advanced age
and pre-existent cerebral atherosclerotic disease than to the
CCA. However, consistent data of Svensson et al. [46], in
an analysis of 656 cases of hypothermic CCA, show a
significant increase of the postoperative stroke rate when
the CCA time exceeds 40 minutes and of the early mortality
with more than 60 minutes. Recently, control of the cerebral
metabolic rate has been proposed by measuring the oxygen
saturation in the jugular bulb, as a parameter to start
hypothermic CCA, but its applicability and safety still need
to be proved [47].
The cerebral retrograde perfusion (CRP) through the
superior vena cava during CCA, first introduced by Ueda
et al. [48], has the advantages of offering controlled brain
cooling, of eliminating metabolites resulting from ischemia,
of removing the air or even debris with emboligenic
potential and of allowing nutritional substrate infusion
during CCA. However, potential limitations such as non-
homogeneous intracerebral distribution, presence of valves
in the jugular system [49], cerebral edema [50], insufficient
cerebral blood flow [51] and bleeding in the operative field
question its use.
Coselli et al. [52] in a recent study of 479 cases of aortic
arch reconstructions, in which hypothermic CCA with CRP
was performed in 290 patients (60%) and isolated
hypothermic CCA in 189 (40%) demonstrated a significantly
lower hospital mortality in the group submitted to CRP (3.4%
versus 6.3%). In respect to the efficacy of the cerebral
protection, favorable findings of CRP were also described
by Safi et al. in a retrospective study of 161 patients submitted
to arch surgery: protection against stroke was three times
higher when CRP was employed (3% versus 9%) and this
benefit was more obvious in over 70-year-old patients.
However, there was no significant difference in the stroke
or death rates between the groups when the CCA time was
less than 60 minutes, which may infer that benefits of CRP
were involved.
In a multicentric Japanese study, coordinated by Ueda
et al. [48] the results of 249 cases of aortic arch replacement
utilizing CRP between 1994 and 1996 were analysed: the
mean CRP time was 46 minutes, the postoperative stroke
rate was 4% and the hospital mortality l3%. A multivariable
analysis identified prolonged CPB time, advanced age and
the urgency of the surgery as the most significant risk factors
related to strokes or death.
Another cerebral protection technique includes
anterograde perfusion during CRP, when cooled blood
infusion via the supra-aortic arteries (cerebroplegia) or
maintenance of perfusion by the axillary artery with
clamping of the brachycephalic trunk can be utilizing. In
the technique originally described by Guilmet et al. [54]
the temperature of the patient is maintained at 25 ºC during
CRP, part of the blood of the oxygenator is cooled to
between 6 and 12 ºC and infused directly into the carotid
arteries at a rate of 200 to 250 mL/min at a pressure of 60 to
70 mmHg. Between 1984 and 1998 the authors utilized CCA
and cerebroplegia in 171 cases of aortic arch replacement,
42 of which were because of type-A dissections. In these
cases the mean CPB time was 121 minutes, the mean
selective cerebral perfusion time was 60 minutes, hospital
mortality was 17% and the occurrence of postoperative
neurological damage was 13% [55].
Although other studies also suggest superiority of
anterograde perfusion over CRP and hypothermic CCA, both
clinically [50,57] and experimentally [56], complications such
as bleeding at the site of cannulation and intra-cerebral
bleeding have restricted its use to only a few centers.
Cannulation of the axillary artery and the maintenance
of the flow through one of the carotids during CCA, as
described by Sabik et al. [57], theorically have several
advantages. These include avoiding handling the femoral
artery, which is often affected by dissections, maintaining
the flow in the anterograde direction through the true lumen
(important when the elephant trunk is utilized), and not
needing deep hypothermia, which minimizes dyscrasic
complications. Additionally, problems of malperfusion of
important organs, and new reentry points are created by a
pressure increase in the false lumen are eliminated, as was
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5demonstrated by Van Arsdell et al. [58]. In this technique,
the axillary artery is dissected near the delta-pectoral groove,
preferable to use  the right side when possible , CPB is
maintained through the D axillary-atrial artery and the
temperature is maintained at approximately 24 ºC. On
establishing CCA, the innominate artery is clamped at its
root and the flow is reduced from 150 to 300 mL/min/m2 to
reconstruct the arch.
The initial experience is promising in a small series [59,60]
but its efficacy and safety still need to be proved.
Recommendations for the surgical treatment of acute
type-A dissections are shown in Table I.
Acute Type-B Dissections
There is still general agreement that surgical treatment
of acute type-B dissections depends on the presence of
complications. These include signs of aortic rupture
(hemothorax, rapid expansion of the aortic diameter,
mediastinal widening), pseudoaneurysm formation, severe
visceral ischemia or ischemia of the extremities, or
progression of the dissection during medicinal therapy
characterized by persistent or recurrent pain. Also cases of
previously aneurysmatic aortas which suffer acute
dissection must be considered for urgent surgery.
However, groups such as the one from Stanford
University demonstrated in a cohort of 136 patients with
acute type-B dissections, that a more aggressive approach
CCA - cardiocirculatory arrest
Table 1. Recommendations for the treatment of acute type-A dissections
Recommendations
1. Immediate surgery to avoid rupture / tamponing / death
2. Straight graft in the ascending aorta, if aortic root and aortic valve are normal
3. Straight graft in the ascending aorta and aortic valvar resuspension, if aortic root is normal and
the valve is insufficient due to loss of support
4. Valved tube, if ascending aorta is dilated or annulus/aorta suffers ectasia and aortic valve is insufficient
5. Auto or homograft, if situation number 4 is associated with endocarditis
6. Aortic valvar resuspension and remodeling of the aortic root in Marfan’s syndrome
7. Partial repair of the aortic arch (hemi-arch repair), if dissection involves the arch, but there is no
destruction or lesion to the intima
8. Total reconstruction of the arch if it presents with intimal destruction or injury
9. In the case of intervention of the arch, open reconstruction using cerebral protection (hypothermic
CCA - cerebral retrograde perfusion – cerebroplegia – axillary perfusion)
10.Saphenous vein grafts, if coronary ostia are affected with delamination and re-implantation is
not possible
Evidence
Class
I
I
I
I
IIA
IIA
I
I
I
I
Evidence
Level
C
C
C
C
C
C
C
C
C
C
might be employed with young, low-operative risk patients,
by early surgery, without increasing hospital mortality (11%),
when compared to medicinal therapy, thereby avoiding
chronic aneurysmatic degeneration of the descending aorta
[7]. Even though these results were extremely favorable,
they were not considered reproducible by other centers.
Indeed, the International Registry of Acute Aortic Dissection
[29] which is considered to be an expression of the real
world reveals that in cases of type-B dissections treated
conservatively, the mortality over 30 days was only 10%,
while in the operated patients the mortality rate was 31%
and the incidence of paraplegia was 18%.
The surgical approach in descending aortic dissections
normally consists of the replacement of the affected portion
using a tubular Dacron graft by left thoracotomy through
the 4th or 7th intercostal spaces, which can be performed with
simple proximal clamping [61,62] with atrial-femoral CPB
either with or without hypothermia [63-66], partial femur-
femoral CPB [67] or even using CCA under deep hypothermia
for a proximal open anastomosis [68]. Depending on the
chosen technique, the dose of heparin and the effects of
the hypothermia level in the cascade of coagulation could
determinate variable effects on the hemostasis or in the
production of dyscrasia.
Another reported technique to repair type-B dissections
is the “elephant trunk” method, initially proposed by Borst
et al. [42] for the surgical treatment of complex aneurysms.
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6After median sternotomy and conventional CPB,
hypothermic CCA is induced and the transverse arch is
opened lengthways; a Dacron tubular graft is introduced
into the proximal portion of the descending aorta and
anastomosed only in the proximal segment after the left
subclavian artery, with the distal end continuing free in the
thoracic aorta. Subsequently, Palma et al. [69] also used this
technique in all cases of acute type-B dissections, in spite
of the existence of complications; the authors performed 70
consecutive insertions of the “elephant trunk” graft,
between 1988 and 1995 by median sternotomy with a short
period of hypothermic CCA (mean time of 31 minutes) and
presented a hospital mortality rate of 20% and an overall
survival over 5 years of 62%.
For the management of renal and mesenteric ischemia or
ischemia of the extremities, specifically when the origin of
these vessels is in the false lumen [70], it is generally
accepted that fenestration by catheter is the method of
choice, which is justified by the high mortality that follows
type-B aortic dissection surgery in these situations: from 50
to 70% in the case of renal ischemia [71,72], 89% in
mesenteric ischemia [71,73-75 ] and up to 87% in peripheral
ischemia [72,74].
Since the first successes using fenestration by balloon-
catheter, to communicate the false and the true lumens, in a
case of type-B aortic dissections with mesenteric ischemia,
which were described by Williams et al. [76] in 1990, several
studies have tried to validate this approach [77-84].
Additionally, the advent of aortic stents, originally utilized
to exclude infra-renal abdominal aneurysms, provided a new
alternative in the management of complicated descending
aortic dissections.
In general, branches affected by static obstructions at
their root are better treated by the intraluminal implantation
of stents, while vessels obstructed by dynamic displacement
of the blood column through a false lumen may be reperfused
by fenestration using a balloon catheter, with or without
stent implantation in the true lumen. In other situations,
stents can be used in the true lumen to maintain the original
position of some branches [83], or to maintain the
fenestration open [85]. Another indication for endovascular
fenestration may be to create a reentry in cases in which a
“dead-end” false lumen significantly compresses the true
lumen, even though this maneuver can increase the risk of
peripheral embolization [85,86] or of aneurysmatic dilations
over the long-term by maintaining the false lumen patent
[83,87].
 The technical objective of fenestration is to create a
‘window’ between the false and true lumens, by “opening”
the intimal layer, normally near to the artery to be saved;
preferentially from the smallest lumen (generally the true
lumen) to the biggest lumen (generally the false lumen),
utilizing a special needle [70,79,84,85] and, if possible,
intravascular ultrasound (IVUS), followed by a 12- to 15-mm
balloon catheter, which is insufflated to promote enlargement
of the ‘window’ [80]. If necessary, a stent of from 10 to 14
mm can be implanted to reduce the possibility of occlusion
of the fenestration, due to a ‘flap’ or thrombosis [85].
The results of reperfusion after percutaneous
fenestration of branches obstructed by aortic dissection,
even those reported in non-controlled studies [83-85,88]
have been consistent: the flow restoration rate varies
between 90 and 100%, the mean mortality over 30 days is
10% and no additional revascularization procedures were
necessary over a mean follow-up of 12 months. Additionally,
all the deaths were related to the irreversibility of the ischemia
at the moment of the intervention, with progression of the
dissection or surgical complications of associated
interventions.
Stent implantation in the descending aorta involves a
great diversity of devices and techniques, with the margin
of the healthy aorta in respect to the left subclavian artery
root, the length of dissection, the existence of a reentry
point and the involvement of visceral trunks being especially
important. The diameter of the endoprosthesis, often
between 2 and 4 cm, is estimated by magnetic resonance,
computed tomography, transesophageal echocardiography
or by IVUS, with the length or the use of more than one
device varying according to the length of the lesion.
Depending on the proximity of the visceral branches, one
part of the prosthesis should not be lined to maintain the
patency of the ostia involved. The right femoral artery is the
commonest insertion site; here the endoprosthesis can be
guided by angiography, IVUS or both methods. Arterial
pressure monitoring is important during implantation,
normally there are increases during the expansion of the
device with a significant drop after its placement. It is
recommended that the mean arterial pressure is maintained
between 50 and 60 mmHg, which requires the use of sodium
nitroprusside [23]. Although the majority of the available
stents are self-expanding, a balloon can be useful to improve
fixation and remodeling of the true lumen.
Preliminary results indicate that the use of stents in
complicated type-B dissections is more reliable and causes
a smaller risk implanted percutaneously when compared to
the implantation by open surgery [89], and that the incidence
of paraplegia maybe be significant with the use of prostheses
longer than 15 cm [89,90]. Thus, when it is necessity to treat
longer segments of the aorta, in cases with distal reentries,
a method using multiple shorter prostheses is preferable,
which has the additional advantage of better modeling in
cases of aortae that present with much curvature. Performing
a carotid-subclavian bypass before implantation may also
be useful in cases where the treated portion is very close to
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7Evidence
Level
C
C
C
C
C
C
B
Table 2. Recommendations for the treatment of acute type-B dissections
Recommendations
1. Clinical management with analgesics and aggressive control of the arterial pressure
2. Surgical treatment, if persistent/recurrent pain, signs of expansion, rupture or bad perfusion
of the extremities
3. Endovascular fenestration, if there is mesenteric or renal ischemia or ischemia of the lower
limbs or neurologic deficits
4. Stent to unblock the visceral branch root, or to maintain the fenestration open
5. Fenestration by balloon and stent implantation, if there is severe compression of the true
lumen, with or without distal reentry
6. Implantation of stent in true lumen to treat compression by false lumen
7. Implantation of covered stent in true lumen to occlude the intimal injury and to promote
thrombosis of the false lumen
Evidence
Class
I
I
IIA
IIA
IIA
IIA
IIA
the root of the left subclavian artery, a maneuver, which in
the experience of Grabenwöger et al. [91], should be
employed in nearly 40% of patients. The short-term follow-
up has demonstrated that the obliteration of the intimal injury
is maintained and the aortic diameter is reduced with the
thrombosis of the false lumen; in cases in which peri-
prosthetic leaks are discovered and in those in which
reentries not seen in the first diagnosis are identified, the
treatment, in general, may be the implantation of another
stent [92].
Recently, an interesting contribution was proposed by
the group of the Escola Paulista de Medicina, (Paulista
Medical School) with the use of percutaneous self-expanding
stents, in all cases of descending aorta dissections. Palma
et al. [93] treated 70 patients with type-B dissections (60%
of which were true dissections and 40% corresponded to
intramural hematomas or penetrating ulcers), with
implantation by the femoral artery of polyester-covered
endoprostheses (Braile Biomedica®), under general
anesthesia, systemic heparinization and induced
hypotension. The procedure was considered a success in
65 (93%) patients, with the exclusion of the false lumen
documented using aortography. In 5 cases (7%) conversion
to surgery was necessary but there were no occurrences of
paraplegia or death. In a mean follow-up of 29 months (from
1 to 55 months), 91% of the patients were alive but the
insertion of additional stents was required in 49% of the
cases. In a more recent report on this series [97] with 120
cases of type-B dissections, the results were consistent:
the hospital mortality was 10%, surgical conversion occurred
in 6 (5%) cases, there were no cases of paraplegia (even
though 2/3 of the descending aorta was excluded in 38 cases
and the treated region was between T9 and T12 in 34
patients) and the long-term survival rate was 87%. The
necessity of implantation of additional stents occurred in
51% of the series, in 14 patients the left subclavian artery
was intentionally occluded using an endoprosthesis and in
only one case, a carotid-subclavian surgical shunt was
necessary [94].
In summary, there are not doubts as to the benefits of
percutaneous intervention techniques in the management
of complications involving the acute descending aortic
dissections, when compared with conventional surgery. Even
so, issues such as whether routine implantation of stents
will substitute the initial medicinal treatment in uncomplicated
cases, as well as the role of endoprosthesis implantation in
the descending aorta during ascending aorta surgeries
remain unclear, in spite of the preliminary promising results.
Table 2 summarizes the recommendations and forms of
interventions in acute type-B dissections.
The long-term follow-up of patients with acute aortic
dissections, operated on or treated using conservative
methods in the acute phase, demonstrates that the false
lumen is maintained patent in about 80% of the cases [95];
additionally, it is known that in only 10% of patients operated
on for type I De Bakey dissections, the false lumen is
maintained obliterated [96-99]. However, this patency should
not be seen as an imminent catastrophic event; often it may
be the main source of blood of some noble organs [95]. In
the experience of the Mount Sinai Medical Center [100],
persistence of a false lumen was associated with a low
incidence of aneurysmatic degeneration and no significant
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18 cases of patent false lumen needed interventions (11%)
and the event-free survival rate over 5 years was 83% for
false lumen with thrombosis and 64% in cases of patent
false lumen (p-value not significant).
The patency of the false lumen after aortic dissection
surgery seems to be more related to the high frequency of
distal reentries than to the success of the exclusion of the
initial injury site. This reinforces the necessity of a follow-
up with extremely rigorous clinical control, in particular in
respect to systemic arterial hypertension (SAH) and imaging
in the 1st, 3rd, 6th and 12th post-procedure months and
thereafter annually [23].
There is agreement that the choice method for long-term
monitoring and eventual indication of intervention should
be nuclear magnetic resonance (NMR) as it avoids exposure
to radiation or to nephrotoxic contrasts used in computed
tomography (CT) and is less invasive than transesophageal
echocardiogram (TEE). A comparison of serial images makes
early detection of increases in the false lumen or of the
entire aorta easy, as well as the identification of the important
visceral branches possible and their relationships to the
dilated portion [101,102].
There is clear evidence that the aggressive management
of SAH with negative inotropic agents is the most important
independent factor in the prevention of chronic
aneurysmatic degeneration or rupture although the use of
beta-blockers are the first-line therapy, as they decrease the
dp/dt. In general the association of more than one drug is
required [23]. As was demonstrated by DeBakey et al. [103]
in 527 patients after acute aortic dissection, aneurysms
developed in 46% of the cases with uncontrolled arterial
pressure, but only in 17% of normotensive patients. Of all
the cases of mortality in the experience of Stanford
University [39,75], at least 15% occurred due to aortic rupture,
while a 20-year follow-up performed by Baylor College of
Medicine [103] revealed that 30% of late deaths were due to
the rupture of chronic aneurysms. In truth, it is estimated
that about 30% of cases operated on for acute aortic
dissection will suffer aneurysmatic degeneration, more
frequently on the thoracoabdominal axis (35%), followed
by proximal descending aorta (14%) [103,104]. Similar data
were published in Europe, where a survival rate of from 70
to 85% is reported in the first year and 60% over two years
in cases of type-B dissections, with the best prognosis in
cases with non-communicant false lumens (80% of survival
over 2 years) [96].
Patients with Marfan’s syndrome must follow familiar
investigations, to anticipate catastrophic events or
recurrences, although cases of multiple interventions are
not rare [105,106]. In this specific group earlier criteria are
considered as commented in the next topic, although the
definitive cutoff point should be defined in still unavailable
longitudinal studies, which would determine the normal
diameter of the aortic root in young patients with Marfan’s
syndrome [107,108]. A moderate restriction of physical
exercise also seems to be beneficial in children and young
adults, because of the potential association of hypertension
and rupture induced by exercise [109].
Information about the natural history of intramural
hematomas (IMH) is limited and sometimes contradictory in
the literature. Generally, this can be considered a condition
as potentially catastrophic as acute aortic dissections
inferring that the mortality rate is significant – from 20 to
80% [110-112]; the evolution to true dissections occurs in
15 of 41% of the cases [112-116], to ruptures in 5% to 26% of
the patients and evolution to spontaneous cure varies
[117,118]. In a recent study of 360 cases of acute aortic
dissections, Nienaber et al. [113] observed that 25 (12%)
cases presented evident false lumen, but without identified
intimal injury in the diagnostic examinations. The mortality
over 30 days, when there was involvement of the ascending
aorta, was 80% in clinically treated cases and zero in operated
patients, similar to the type-A aortic dissection. Vilacosta et
al. [118] analysed the evolution of 21 cases of IMH, of which
15 were spontaneous – 8 involving the ascending aorta and
7 confined to the descending portion – and 6 were caused
by trauma. In the group considered type-A, 3 (37%) cases
evolved to sudden death, 3 (37%) were successfully operated
on and 2 (25%) evolved to a cure. In the type-B group 1
(15%) sudden death occurred and 6 (85%) had favorable
clinical courses by medicinal therapy, while in the trauma
group there were spontaneous cures in 3 (50%) patients.
Another 3 cases (50%) in this group evolved to death, but
due to causes not related to ruptures. Even though the
sample was small, the authors suggest that the natural history
of IMH is better in trauma or cases restricted to the
descending aorta than cases that involve the ascending
aorta.
The evolution of ulcerated aortic plaque is also not
completely known and controversial,  in the few reports
available. While some authors consider that it is as
dangerous as true acute aortic dissections with a high
possibility of rupture, others point out its benign clinical
course that does not require immediate surgical treatment
[119,120]. However, the existence of sub-intimal hematomas
or penetrating ulcers should be viewed as possible imminent
ruptures. In a retrospective study of 198 aortic dissection
cases, the group from Yale University [121] detected the
presence of 15 penetrating ulcers (8%), identified in imaging
examinations prior to the acute event, of which 13 (87%)
were found in the descending aorta. The mean age and the
size of the aorta in this group were significantly higher than
in the total sample and an association with infra-renal
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C
Table 3. Recommendations to the follow-up of patients with aortic dissection
Recommendations
1. Continuous control of systemic arterial hypertension with beta-blockers
2. Imaging examinations (NMR, CT etc)
3. Moderate restriction of physical exercises
Evidence
Class
I
I
I
NMR – nuclear magnetic resonance; CT – computed tomography;
abdominal aortic aneurysms was seen in 40% of these
patients, with ruptures seen in the hospital evolution in
approximately 40% of the cases. The development of
pseudoaneurysms in these ulcerated plaques is another
complication observed over the long-term [122,123], with
the development of true dissections estimated in from 10%
to 20% of the cases [23].
The recommendations for the long-term follow-up of
patients after suffering from acute aortic dissections are
illustrated in Table 3.
CHRONIC DISSECTIONS – THORACIC ANEURYSMS
Ascending Aorta - Aortic Arch
The aorta is considered pathologically dilated when its
diameter exceeds the normal for a specific age and body
surface area. When the diameter is more than 50% of the
expected size, the segment is considered aneurysmal.
In the ascending aorta, progressive dilation can lead to
aortic valve insufficiency (even in anatomically normal
valves), to acute dissection or to spontaneous rupture.
These are events which dramatically change the natural
history and survival and the amount of risk is related to
the diameter and to the type of structural disease of the
aortic wall.
Indications for the surgical replacement of the ascending
aorta in patients with Marfan’s syndrome, acute dissections,
intramural hematomas or endocarditis with extensive annular
damage are supported by consistent evidence. However,
the moment of the intervention in asymptomatic patients
with degenerative dilations, as well as in the association of
dilation of the aorta with the bicuspid aortic valve, remain
uncertain.
In Marfan’s syndrome, there is an agreement that
prophylactic surgical repair is indicated when the diameter
reaches 5.5 cm, although it may be smaller (from 4.5 to 5 cm)
in patients with familiar history of dissections, ruptures or
sudden death [23,107,124-128]. In the other cases, although
the presence of symptoms or the severity of aortic
insufficiency can indicate intervention, independent of the
aortic size, it is generally accepted that a diameter of 6 cm is
indicative of surgery in asymptomatic aneurysms [23,129].
Even so, groups such as that of the Mount Sinai Medical
Center [16], based in its recent experience, have proposed
differentiated criteria for intervention, such as diameters of
4.3 cm in under 40-year-old adults with Marfan’s syndrome,
from 4.8 to 5 cm in cases found by chance during heart
surgery for different diseases and 4.5 cm in surgeries of
bicuspid aortic valves [16].
The aortic root or descending aorta surgical
reconstruction options have already been described
previously. In cases of chronic aneurysms, some aspects
can contribute to the choice of the technique, as proposed
by Ergin et al. [16]:
- Age and life expectation in very old or high surgical
risk patients, valve replacement and the reduction in the
caliber of the aorta by a lengthways suture with support
may be a good alternative [130]; equally, valve replacement
followed by the implantation of a Dacron straight graft,
separately, can be appropriate for patients with limited life
expectation [131];
- Quality of aortic wall: a weakened aorta as in acute
dissections or in Marfan’s syndrome generally requires
removal of all friable tissue of the aortic root and of the
ascending portion; in these cases, the Bentall button
technique can be useful [14] or valve remodeling [132];
- Anatomy of the aortic valvar apparatus – Valsalva’s
sinus - Sinotubular portion: when there is dilation of the
apparatus, Bentall button-type valved tube implantation [14]
or the use of thetechnique described by Cabrol et al. [17] or
exceptionally auto/homografts. If the valve is normal but
there is dilation of the sinus or of the sinotubular region,
valve remodeling techniques as suggested by Tirone David
can be employed [24];
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- Anticoagulation risks: in patients at considerable risk
of bleeding, the remodeling techniques or auto/homografts
must be given preference;
- Association with aortic valvar endocarditis: although
there is no conclusive evidence, the majority of groups
recommend auto or homografts in this situation.
-
- Using this systematization, Mount Sinai Medical
Center group recently published their experience of 497 cases
of annulus-aortic or ascending aorta reconstruction in mainly
elective surgeries (n=310), corrected using the Bentall button
technique (n= 250). The overall hospital mortality was 8%
and 5.5% when excluding urgent surgeries; in the 250 cases
of the modified Bentall technique the hospital mortality was
only 4% and the reoperation-free survival rate was 79%
over 5 years and 62% over 8 years, results that substantiate
the authors recommendation of this technique [16].
In respect to aneurysms located in the transverse arch,
the currently accepted indications for surgical resection
include: 1) an absolute diameter > 6 or 7 cm, or greater than
two times the expected diameter for that patient; 2) growth
in the diameter greater than 7 or 10 mm per year; 3) pain or
symptoms of compression and 4) saccular aneurysms [133,
134] Patients with Marfan’s syndrome generally are indicated
for early surgery, with growth greater than 3 to 5 mm per
year, or absolute diameters of 5 cm [135]. Technical details
referring to the surgical repair methods and cerebral
protection described in acute dissections involving the
transverse arch are applicable here too.
Descending Aorta – Thoracic-abdominal
In asymptomatic patients with descending aorta
aneurysms (DAA), the identification of predictors of
dissection, rupture and death have been exhaustively
studied, attempting to establish a safe cutoff point to indicate
surgery, as the mortality and the operative morbidity rates
are significantly higher than in ascending aortic surgery.
Thus, some complicated exponential equations have been
proposed to calculate an estimation of acute events in cases
of DAA [136,137]. The group from Yale University has
performed consistent and simplified studies [74,129,133,138],
showing the diameter as the most relevant independent risk
factor for complications. Based on a database of 721 patients
with DAA, the authors followed the evolution of 304
asymptomatic cases, with a minimum diameter of 3.5 cm and
clearly demonstrated that the incidence of associated
complications – rupture, dissection or death – was 15.6%
for aneurysms with diameters of from 5 to 6 cm and only
3.9% for diameters between 4.0 and 4.9 cm (p=0.004). When
analysed separately ruptures, the Odds ratio increased 27
times when the diameter reached 6 cm when compared to
cases of 4.0 cm or less (p=0.002). Additionally, the 5-year
survival curve of patients with diameters > 6 cm was only
56% and 85% for elective operations (p=0.003), survival
similar to that found in the normal population with the same
mean age. These findings, associated with operative
mortality of 11% presented by the group [139] have led the
authors to choose 6 cm as the parameter for the surgical
indication of DAA, a conduct considered consensual by
specialists [23].
The principal problem in the surgical repair of descending
or thoracic abdominal aneurysms is still paraplegia, with an
incidence reported at between 4 and 32% in recent works
[140-151]. Indeed, medullar injury still is a devastating event
for the patient, family and surgical staff. Although
paraplegia is clearly multifactorial, it occurs due to one or
more of the following conditions: 1) duration and degree of
medullar ischemia; 2) failure to reestablish the blood flow to
the spinal column after repair and 3) biochemical-mediated
reperfusion injury.
To reduce medullar ischemia, many techniques have been
recommended, with conflicting clinical results. When no
method of distal perfusion is used during the reconstruction,
the aorta should only be clamped proximally, as
recommended by Crawford et al. [152], to impede increases
in the CSF pressure, the level of the clamping should be
lowered gradually, as the main intercostal branches and the
visceral branches are anastomosed to the prosthesis. While
ischemia times of less than 30 minutes are relative safe, this
approach presents with an unacceptable incidence of
paraparesis or paraplegia with times greater than 60 minutes
[153]. In contrast, when distal perfusion is maintained to
optimize the nutrition of the intercostal and lumbar arteries,
short periods of sequential ischemia can be performed; in
this technique, CPB is established by left atrium-femoral or
femur-femoral vessels which allows the maintenance of
perfusion up to the T5 or T6 level during the first clamping
of the proximal aorta and of the left subclavian artery.
Concluding the proximal anastomosis, the distal clamp is
usually placed just above the celiac trunk and the main
intercostal vessels are included in the graft. In the next step,
the clamp of the prosthesis is placed below the intercostal
arteries and the distal aorta clamp below the renal arteries,
which are included as a block or individually. Subsequently,
the aortic clamping is transferred to the infra-renal portion
and the distal repair is concluded. With this approach of
sequential ischemia there has been a significant reduction
in the rates of paraplegia and renal insufficiency [7].
Other methods of distal protection may include CPB with
hypothermic cardiocirculatory arrest or the use of temporary
internal or external shunts. While Kouchoukos et al. [68]
supported by incidences of 6.5% for paraplegia and of 10%
for death over 30 days, recommended total CPB with CCA
under deep hypothermia, Crawford et al. [154] considered
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this technique particularly useful in aneurysms that involve
part of the arch or in arches extensively calcified in their
proximal portions, presenting paraplegia and mortality rates
of 9.5% and 16% respectively.
Alternatively, several types of temporary shunts have
been proposed, justified by the necessity of smaller doses
of heparin and because they do not exclude hypothermia,
thereby minimizing bleeding complications. The greatest
experience in the literature was published by Verdant et al.
[155] who utilized aorto-aortic or aorto-femoral bypasses in
366 consecutive cases of DAA, giving hospital mortality of
12% and no cases of paraplegia; however and curiously,
even with these highly positive results, the authors now
recommend atrio-femoral CPB due to the significant
incidence of strokes and of aortic injuries at the sites of the
shunts.
Drainage of cephalic-rachidian liquid (CRL) to reduce
the intrathecal pressure constitutes another form of medullar
protection, widely tested in several animal models,
associated or not with infusion of neurotropic-negative
drugs [156-163].
Preliminary studies performed in the Mayo Clinic were
favorable to the protector effect of CRL drainage, but the
subsequent results did not demonstrate significant benefits
[164]. Other groups have defended CRL drainage associated
with the local infusion of naloxone [143] or during atrio-
femoral CPB [165].
Although Acher et al. [143] in a non-controlled study
suggested that naloxone associated with CRL drainage can
even dispense with the re-implantation of intercostal arteries;
no benefits of this technique were evidenced in subsequent
randomized trials [166] making its use empirical.
The effect of epidural administration of papaverine on
the function of spinal medulla has been referred to as having
a promising effect.
In experimental models of thoracic aorta clamping for up
to 60 minutes at normothermia, an intrathecal injection of
papaverine was highly effective in preventing paraplegia,
demonstrating a significant increase in the blood supply in
the anterior portion of the spinal medulla by the use of
radionuclides [159]. At a clinical level, removal of a small
volume of CRL followed by the intrathecal application of
papaverine, also showed potential benefits in some non-
controlled prospective studies [149,167], motivating further
clinical trials [168].
Other pharmacological agents proposed as adjuvant in
the prevention of paraplegia include corticosteroids [144],
lidocaine [144], mannitol [169], magnesium sulphate [161],
prostaglandins [153], allopurinol [170], flunarizine [171], but
none has proved to be effective in the clinical practice.
A consensual recommendation discusses the necessity
of re-implantation of the maximum number of main intercostal
arteries, particularly in the lower 1/3 of the thorax and upper
abdomen, between T7 and L1 [168]. Several anatomic studies
have already demonstrated that the blood supply to the
medulla at the thoracic level is predominantly supplied by
the intercostal arteries between T4 and T12 and by the lumbar
arteries between L1 and L4 [172-174] and that in more than
90% of patients the most important radicular artery, referred
to as the Adamkiewicz artery or radicular magna, emerges
between T7 and L1. In chronic processes such as
atherosclerotic aneurysms there can be development of
collateral circulation capable of maintaining the medullar
functioning, even when there is extensive sacrifice of
intercostal branches, or when early thrombosis of some
intercostal paths is an arteriographically documented event
[175], all effort must be made to protect these vessels. Thus,
preservation of the posterior wall of the terminal thoracic
aorta as proposed by Williams [176] can be a valid conduct.
Due to the diversity of anatomic variations in the medullar
blood supply that can include from a well-developed and
easily identified magna radicular artery, or many large caliber
terminal intercostal arteries or, even, many small caliber
arterioles, intraoperative mapping models of the segmental
arteries have been tested, aiming at selecting arteries to be
re-implanted and to reduce the aortic clamping time, such as
the intraoperative infusion of hydrogen to identify
intercostal branches that effectively contribute to medullar
perfusion [177].
Similarly, many experimental and clinical studies [47, 154,
159, 178-184] have been developed trying to define the role
of the motor-evoked or somatosensorial potentials, in
monitoring the activity of the segmental medulla and in the
prevention of the paraplegia, although with very variable
results and with recommendations still not consensual in
respect to the efficacy as an isolated method in the
prevention of medullar ischemia [179].
Crawford et al. [172] prospectively analyzed the role of
the somatosensory evoked potentials (SSEPs) in a
randomized trial of 198 patients submitted to DAA or
thoracoabdominal aortic aneurysms correction. As not only
did monitoring SSEP not demonstrate a protecting
neurological effect, there were incidences of 13% false-
negative and 67% false-positive cases in the responses of
the monitored group, leading the authors to believe that
there is no sustenance for this technique.
As mentioned in the section about acute dissections, an
innovative and highly promising approach in the treatment
of DAA is the implantation of self-expanding stents,
developed by the Stanford University group [185].
Preliminarily, the authors used the percutaneous
implantation of self-expanding stents covered by Dacron in
the femoral artery in 13 cases of chronic thoracic aneurysms
with a mean diameter of 6.1 cm. An immediate exclusion was
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Level
C
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B
Table 4. Recommendations for the surgical treatment of chronic thoracic aorta/ thoracic-abdominal aneurysms
Recommendations
Ascending aorta
1. Surgery, if there are compression symptoms, aortic insufficiency or aortic diameter > 6.0 cm
2. In Marfan’s syndrome, prophylactic surgery if diameter > 5.5 cm or > 5.0 cm in cases with
familiar history of dissection or sudden death
Descending aorta
1. Surgery, if symptoms or aortic diameter > 6.0 cm
2. Stent implantation, if aortic diameter > 6.0 cm and favorable anatomy
Evidence
Class
I
IIA
I
IIA
observed in 12 patients and no deaths or cases of paraplegia
in the hospital phase were reported and not even over a
mean follow-up period of 11.6 months. In a clinical assay
developed subsequently [90], the same authors amplified
the experiment to 103 implantations, the majority of which
had prohibitive surgical risk and obtained immediate success
rates of 83%. The early mortality was 9%, paraplegia was
observed in 3% of the patients and 7% developed ischemic
strokes during the hospital stay. The long-term follow-up of
3.7 years demonstrated an event-free survival rate of 53%
and the group started to recommend this technique for
selected high operative risk patients. However, the greatest
experience with the percutaneous exclusion of DAA was
published recently by Buffolo et al. [94]. Between 1996 and
2002 191 stent implantations were performed in cases of
type-B dissections (n=120), true thoracic aneurysms (n=61),
deep ulcer hematomas (n=6) and trauma of the descending
aorta (n=4). For all patients the authors used general
anesthesia, induced hypotension (mean arterial pressure
between 50 and 60 mmHg), heparinization only during the
procedure (5000 IU/IV) and polyester-covered stents (Braile
Biomédica ®), the sizes of which were calculated as 10% to
20% bigger than the diameter of the aorta. The success rate
of the implantation, defined as the obliteration of the intimal
laceration or the complete exclusion of the aneurysms
without extravasation, was 91% [144,183], the hospital
mortality was 10%, conversion to surgery was necessary in
6 cases (3%) and no cases of paraplegia were observed.
If these results will be confirmed in subsequent studies,
may represent the most important advance in the treatment
of a cardiovascular disease which has extremely high
morbidity and mortality rates and is one of the most
challenging for surgeons: the thoracic and thoracic-
abdominal aneurysms.
Table 4 presents recommendations for the management
of chronic aneurysms of the thoracic aorta.
Abdominal Infra-renal Aorta
In few situations, surgical intervention called
“prophylactic” has had such a great impact in the
modification of the natural history of a disease, as in the
case of infra-renal abdominal aneurysms (AAA), not only
due to its high prevalence (from 90% to 95% of all cases of
aortic aneurysms), but also due to the increase in morbidity
and mortality that follow its emergency repair (the mortality
risk is 10 times greater than in elective surgeries). To establish
guidelines for the indication of elective repair of AAAs,
aiming at assisting decision making, some aspects about
the pattern of this disease must be considered.
Abdominal aneurysms are often found by chance,
mainly in old people. Many studies have estimated that
AAA are found in 2% of people with from 60 to 69 years of
age and approximately 5% of  over 70-year-olds and it is 2 to
3 times commoner in men than in woman [186, 187].
The association of AAA with some diseases is well
known and relatively predictable: it is known that AAA is
found in about 5% of patients with coronary atherosclerosis
[188], 9% of peripheral artery disease cases [189] and from
30% to 50% of the patients with popliteal or femoral
aneurysms [190].
AAA is easily detectable by clinical examination and by
non-invasive diagnostic methods. In general, an experienced
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physician can detect aneurysms of 5 cm in diameter directly
by palpation, but the precision of the diagnosis only by
touch is < 50%, while ultrasound is able to diagnose AAAs
of any diameter in 100% of cases.
Ruptures of AAAs are considered a severe public health
problem: It is estimated at 15,000 deaths per year in the USA
of cases that reach hospital and maybe two or three times
this number if all cases of sudden death by AAA that occur
out of the hospital are included [187].
Ruptures of AAAs are more related to large aneurysms,
to rapid growth or to the recent initiation of symptoms. The
risk of rupture over 5 years for aneurysms smaller than 5 cm
in diameter is estimated as less than 5%, while in aneurysms
larger than 5 cm the accumulated risk is from 25% to 43%
[191-195]. Multivariable analysis of some studies identified
rapid expansion and the presence of significant abdominal
or low back pain as the most important predictors for rupture,
independently of the size of the AAA [196-198].
Small aneurysms grow at a variable speed: although it is
estimated that the mean expansion of AAAs must be about
0.4 cm/year, there is a great variability making it impossible
to predict the evolution in a specific patient [199].
The risk of death or worse complications with elective
surgery of AAA is dependent on the experience of the
surgical group and on the numbers of surgeries in the
hospital, but currently the mortality rate must be lower than
5%. Although metanalysis of recent studies point to a mean
mortality rate of 3.5% [192,194,200-206], a variation of up to
10% is observed between surgeons and institutions [207].
The presence of symptoms in AAAs is a consensual
surgical indication independent of the diameter. These
symptoms include pain/lumbar or abdominal discomfort,
distal embolization or signs of compression of neighboring
structures. Obviously, emergency surgery is essential in
the cases when rupture is suspected.
Also aneurysms of an inflammatory etiology are
indicative of elective repair independent of the size, as they
are followed by significant systemic manifestations, such
as fever and weight loss [187].
For asymptomatic patients, the indication of
intervention must consider the risk of rupture versus the
operative risk of the individual and the life expectancy. In
the 1990s, the International Society for Vascular Surgery
recommended elective surgeries for AAAs with diameter
exceeds 5.0 cm, or even 4.0 cm in patients with chronic
obstructive bronchopulmonary disease based on the low
postoperative mortality rate found in this group (1%)
[187,195]. There was also a clear recommendation to
contraindicate the surgical repair of AAAs of any size when
metastatic neoplasias, severe heart insufficiency or other
conditions that limit survival to no more than 2 to 3 years
are observed [187].
However, results of 2 recent large clinical trials may
change these criteria.
In the United Kingdom in the ‘Small Aneurysm Trial’
[208] 1090 patients with asymptomatic aneurysms with
diameters between 4.0 and 5.5 cm were randomized for
conservative treatment with serial ultrasound examinations
or elective surgical repair and follow-up over a period of
from 6 to 10 years (mean 8 years). The operative mortality
rate was 5.5% and survival over 8 years was similar in both
groups, although slightly better in the group that underwent
interventions after this period. No differences were observed
in this pattern in respect to age, gender or initial size of the
aneurysm and the authors concluded that patients with
asymptomatic AAAs with diameters up to 5.0 cm can be
conservatively followed-up, without additional risks.
The findings were also confirmed in the Aneurysm
Detection and Management Veterans Affairs Cooperative
Study [209], in which 1136 patients with infra-renal
aneurysms with diameters of between 4.0 and 5.4 cm were
randomized for surgical treatment (n=569) or for periodic
echographic control (n=567). The hospital mortality in the
operated group was 2.7% and there was no difference in
the 5-year survival rate between the two groups. There
was no reduction in the death rate related to complications
of the AAA in the group submitted to intervention (3%
versus 2.6%) and the rupture risk in the non-operated
patients was minimal (0.6% per year). However, the authors
did not recommend elective surgery for AAAs with
diameters of up to 5.4 cm, even when the surgical mortality
of the group was low.
On the other hand, the high incidence of ruptures of the
AAAs with diameters > 5.5 cm has been well documented
by the same authors [210] in a cohort of 198 patients with
absolute contra-indications for surgical repair. The annual
rupture rate was 9.4% for diameters between 5.5 and 5.9 cm;
10.2% for cases between 6.0 and 6.5 cm; 19% between 6.6
and 7.0 cm; and of 32.5% in patients with diameters > 7.0 cm,
results that corroborate those of previous studies.
The interventionist therapy using stent implantation has
recently been proposed as an alternative to the surgical
treatment of AAAs. Since Parodi et al. [211] performed the
first percutaneous exclusion of an intra-renal aneurysm 12
years ago many devices have been developed and tested,
without arriving at an agreement that this technique may
substitute conventional surgery.
The current results point to an immediate success rate
near 95%, with conversion to surgery in between 3% to 5%
of the cases and a hospital mortality rate of approximately
3%. The commonest early complications are inguinal
hematomas (7%), arterial thrombosis (3%) and rupture of
the iliac artery (1.5%). Over the long-term, endoleaks have
been demonstrated in from 10% to 20% of the cases, with
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Table 5. Criteria of intervention in intra-renal aortic aneurysms
Recommendations
1. Surgical treatment – if symptoms – lumbar or abdominal pain, compression of vertebral
body or adjacent structures
2. In asymptomatic cases, surgery, if diameter > 5.5 cm and low operative risk / long life
expectation
3. Consider diameters of 6 cm, if high operative risk
4. Stent implantation, if high surgical risk and favorable anatomy
Evidence
Class
I
I
I
IIA
spontaneous solutions in from only 40% to 50% of them
[212]. When stent implantation and conventional surgery
are compared, as in the studies by Hallet et al. [213] and
May et al.[214] there are no significant differences in the
early mortality and morbidity, however the event-free
survival rate over 2 years is notably better in surgical group
(93% versus 67%).
In conclusion, based on the most recent Guidelines of
the American Association for Vascular Surgery and the
Society for Vascular Surgery we may state that: 1) Low risk
asymptomatic patients should be considered for elective
surgery with a minimum diameter of 5.5 cm (in women the
diameter may be 5.0 cm); 2) Significant perioperative risk
cases with 6.0 cm; and 3) the optimal clinical management
must include control of hypertension and cessation of
smoking. Endovascular therapy may be a valid alternative
in high risk surgical patients, although this is a not
consensual [215].
Table V presents the current criteria of intervention in
cases of AAA.
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NOTE OF THE EDITOR
Following this we have published the comments of Dr.
Joseph Coselli in respect to the Guidelines for the Surgical
Treatment of Aortic Diseases. The idea is to enrich the
knowledge of the BJCVS readers and to try to adequately
implement the guidelines in the medical practice.
COMMENTS
Dr. Joseph COSELLI
In first place, I would like to congratulate the authors for
the extremely well-written manuscript, preparing the
guidelines for surgery of aortic diseases. I would like to
append some comments and contributions.
In type-A dissections, the risk of imminent death due to
rupture or congestive heart failure by sudden aortic
insufficiency and severe complications from arterial branch
occlusion, such as brain strokes or ischemia of the extremities,
reinforce the necessity of early recognition of this situation.
In respect to the location of arterial perfusion, I would like
to stress that the use of the right axillary artery cannulated
directly or through a Dacron graft, as opposed to the femoral,
artery has become the first-line technique in the correction
of dissections and is routinely used by our team.
In relation to the technical alternatives when dissection
occurs at a root of the previously dilated aorta, I would like
to suggest, as an alternative, the possibility of using
stentless biological valves which were recently approved
for clinical use in the USA. In relation to the technique
described by Cabrol et al. for the re-implantation of the
coronary ostia, it was well remembered by the authors that
we have preferred to use them in reoperations where fixing
of the mediastinum, due to the presence of adherences,
impedes great mobilization of the ostia or the coronary
buttons. I completely agree with the authors about the
validation of biological adhesives as adjuvant of hemostasis
in the correction of acute dissections. I would only like to
add the possibility of using Cryolife Bioglue adhesive which
was also approved by the FDA. In respect to the levels of
hypothermia described by the authors, when treating
transverse arches, I totally agree and add the alternative of
using isoelectric EEG as a parameter to determine the lower
limit of the systemic temperature and include that the use of
anterograde brain perfusion, in general, allows the correction
at higher temperatures, such as 28 ºC or even 32 ºC.
I congratulate the authors on their use of the data from
the International Registry of Acute Aortic Dissection, as
they are a real picture of the world and not the result of
selected series coming from high-reference institutions that
often present much more favorable results.
In type-B aortic dissections, the authors appropriately
mention the benefits of percutaneous interventions
compared to conventional surgery in the management of
complicated cases. However, caution should be taken in
cases of diseases of the connective tissue (as for example
Marfan’s syndrome and Ehlers-Danlos), in re-dissections,
or in acute dissections overlapping chronic dissections
where more than two lumens might be present.
On the medulla protection methods in descending aortic
surgeries, I would like to stress the role of drainage of the
cerebrospinal liquid in diminishing the incidence of
paraplegia, in cases of more extensive thoraco-abdominal
aneurysms as demonstrated in several trials and additionally
the use of left femoral-atria circulation assistance that seems
to be beneficial for the same reason.
Once again I congratulate the authors of the Guidelines
for the Surgical Treatment of Aortic Diseases of the Brazilian
Society of Cardiovascular Surgery for their excellent work
and really hope that my comments will be helpful.
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